This two-volume Handbook provides a major thematic overview of global sexualities, spanning each of the continents, and its study, which is both reflective and prospective, and includes traditional approaches and emerging themes. The Handbook offers a robust theoretical underpinning and critical outlook on current global, glocal, and 'new' sexualities and practices, whilst offering an extensive reflection on current challenges and future directions of the field. The broad coverage of topics engages with a range of theories, and maintains a multi-disciplinary framework. PART ONE: Understanding Sexuality: Epistemologies/Conceptual and Methodological Challenges; PART TWO: Enforcing and Challenging Sexual Norms; PART THREE: Interrogating/Undoing Sexual Categories; PART FOUR: Enhancement Practices and Sexual Markets/Industries; PART FIVE: Sexual Rights and Citizenship (And the Governance of Sexuality); PART SIX: Sexuality and Social Movements; and PART SEVEN: Language and Cultural Representation.
Chapter 22: Questioning the ‘Viagrization’ of (Hetero)Sexual Ageing
Questioning the ‘Viagrization’ of (Hetero)Sexual Ageing
In 1998 Pfizer developed Viagra, one of their top-selling drugs, earning $2 billion worldwide in 2012 alone (CBS News, 2013). According to the company, about 30 million US men suffer from ‘erectile dysfunction', and Viagra has been prescribed for more than 23 million of these (Pfizer, 2016). The drug, initially produced for older men with medically related erectile difficulties (Lexchin, 2006), functions by increasing the flow of blood to the penis. After its release, the company marketed the drug to a broader sector of men desiring harder, longer-lasting erections, thereby transferring attention from ...